Although the network ‘glucocorticoid receptor signaling’ targeted by many drugs does not contain autoimmune disease genes (e.g. MS, SLE and RA), dysregulation of glucocorticoid production at a previous step before the network may play a key role in various autoimmune diseases (42). This evidence concerns the gene NR3C1 and systemic lupus erythematosus.